Herbert Virgin - 14 Dec 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: EVP, Research & CSO
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 14 Dec 2021
Net transactions value: -$194,274
Form type: 4
Filing time: 16 Dec 2021, 16:04:44 UTC
Previous filing: 02 Dec 2021
Next filing: 30 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$2,104	+1,375	+1.3%	$1.53^*	109,075	14 Dec 2021	Direct
transaction	VIR	Common Stock	Sale	$63,085	-1,375	-1.3%	$45.88	107,700	14 Dec 2021	Direct	F1
transaction	VIR	Common Stock	Options Exercise	$4,208	+2,750	+2.6%	$1.53^*	110,450	15 Dec 2021	Direct
transaction	VIR	Common Stock	Sale	$137,500	-2,750	-2.5%	$50.00^*	107,700	15 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-1,375	-0.6%	$0.000000	229,130	14 Dec 2021	Common Stock	1,375	$1.53	Direct	F2
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-2,750	-1.2%	$0.000000	226,380	15 Dec 2021	Common Stock	2,750	$1.53	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2	1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.